Dr. Jerrold Winter
Pharmacology And Toxicology
102 Farber Hall
School of Medicine and Biomedical Sciences
University at Buffalo
Buffalo NY, 14214
Phone: (716) 829-3239
Fax: 716 829 2801
Email: jcwinter@buffalo.edu

View map


DESCRIPTION OF INTERESTS

Research in my laboratory centers on the study of psychoactive drugs with special emphasis on nootropics and drugs of abuse.

In collaboration with Dr. Richard Rabin of this department, behavioral data are correlated with biochemical indices of drug action in an attempt to understand at the receptor level the effects in intact animals of psychoactive drugs. Behavioral data are obtained using the techniques of operant behavior with special emphasis on the phenomenon of drug-induced stimulus control. Current interests include the serotonergic basis for the actions of indoleamine and phenethylamine hallucinogens including LSD and [-]-DOM as well as their interactions with selective monoamine reuptake inhibitors such as fluoxetine [Prozac]. In the area of nootropics, recent studies have examined the effects of EGb 761, an extract of Ginkgo biloba; for these investigations, a delayed non-matching to position task in a radial
maze is employed. Currently, studies are in progress to assess the serotonergic basis for the cognitive effects of drugs of abuse including LSD and MDMA [Ecstasy].

Behavioral pharmacology of psychoactive drugs, including psychotherapeutic agents and drugs of abuse; mechanisms of action of hallucinogens.

Research in Dr. Jerrold Winter‘s laboratory seeks to understand the ways in which drugs alter behavior. Many chemicals are candidates for study but attention in the last few years has centered on hallucinogens such as LSD, phencyclidine, DOM, and ibogaine. Another area of major interest is age-related memory impairment and those natural materials,
including ginseng and gingko biloba, which are purported to influence that impairment. The behavioral effects of these drugs are studied in rats trained with the techniques of operant conditioning. Specific variables in use at the present time include drug-induced stimulus control, radial maze acquisition and performance, and conditioned place preference and
aversion.

In addition, Dr. Winter actively collaborates with Dr. Richard Rabin of the Department of Pharmacology and Toxicology in order to correlate behavioral effects with biochemical indices of action at the receptor level and with functional efficacies in second messenger systems.


EDUCATION

1966 Ph.D., Pharmacology
State University of New York at Buffalo
1959 Bachelor of Science, Organic Chemistry
University of Rochester


PUBLICATIONS

Reissig CJ, Rabin RA, Winter JC, Dlugos CA; d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex.; Eur J Pharmacol; 2008 Mar; 583(1); 40-47
Krall CM, Richards JB, Rabin RA, Winter JC; Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice.; Pharmacol Biochem Behav; 2008 Jan; 88(3); 349-357
Reissig CJ, Eckler JR, Rabin RA, Rice KC, Winter JC; The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.; Pharmacol Biochem Behav; 2008 Jan; 88(3); 312-317
Winter JC, Rice KC, Amorosi DJ, Rabin RA; Psilocybin-induced stimulus control in the rat.; Pharmacol Biochem Behav; 2007 Oct; 87(4); 472-480
Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH; Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.; Pharmacol Biochem Behav; 2006 Jan; 83(1); 122-129
Reissig CJ, Eckler JR, Rabin RA, Winter JC; The 5-HT1A receptor and the stimulus effects of LSD in the rat.; Psychopharmacology (Berl); 2005 Oct; 182(2); 197-204
Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH; Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.; Psychopharmacology (Berl); 2005 Sep; 181(3); 496-503
Doat-Meyerhoefer MM, Hard R, Winter JC, Rabin RA; Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.; Pharmacol Biochem Behav; 2005 Aug; 81(4); 750-757
Winter JC, Kieres AK, Zimmerman MD, Reissig CJ, Eckler JR, Ullrich T, Rice KC, Rabin RA, Richards JB; The stimulus properties of LSD in C57BL/6 mice.; Pharmacol Biochem Behav; 2005 Aug; 81(4); 830-837
Winter JC, Eckler JR, Rice KC, Rabin RA; Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.; Pharmacol Biochem Behav; 2005 Jul; 81(3); 694-700
Muschamp JW, Regina MJ, Hull EM, Winter JC, Rabin RA; Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.; Brain Res; 2004 Oct; 1023(1); 134-140
Eckler JR, Reissig CJ, Rabin RA, Winter JC; A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat.; Pharmacol Biochem Behav; 2004 Sep; 79(1); 25-30
Regina MJ, Bucelli RC, Winter JC, Rabin RA; Cellular mechanisms of serotonin 5-HT(2A) receptor-mediated cGMP formation: the essential role of glutamate.; Brain Res; 2004 Apr; 1003(1-2); 168-175
Winter JC, Eckler JR, Rabin RA; Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.; Psychopharmacology (Berl); 2004 Mar; 172(2); 233-240
Regina MJ, Buccelli RC, Winter JC, Rabin RA; Cellular mechanisms of serotonin 5-HT2A receptor-mediated cGMP formation: the essential role of glutamate.; Brain Research; 2004; 1003; 168-175
Regina MJ, Winter JC, Rabin RA; Characterization of a novel effect of serotonin 5-HT1A and 5-HT2A receptors: increasing cGMP levels in rat frontal cortex.; Neuropharmacology; 2003 Dec; 45(8); 1041-1049
Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC; Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.; Pharmacol Biochem Behav; 2003 Jul; 75(4); 845-852
Eckler JR, Rabin RA, Winter JC; Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.; Pharmacol Biochem Behav; 2003 May; 75(2); 405-410
Doat MM, Rabin RA, Winter JC; Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.; Pharmacol Biochem Behav; 2003 Feb; 74(3); 713-721
Winter JC, Eckler JR, Doat MM, Rabin RA; The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.; Pharmacol Biochem Behav; 2002 Dec; 74(1); 95-101
Eckler JR, Doat MM, Rabin RA, Winter JC; Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: role of pharmacokinetics.; Life Sci; 2002 Aug; 71(11); 1341-1347
Doat MM, Rabin RA, Winter JC; The effect of chronic treatment with clozapine and haloperidol on stimulus control by DOM.; Int J Neuropsychopharmacol; 2002 Jun; 5(2); 153-158
Rabin RA, Regina M, Doat M, Winter JC; 5-HT(2A) receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.; Pharmacol Biochem Behav; 2002 May; 72(1-2); 29-37
Rabin RA, Regina M, Doat M, Winter JC; 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.; Pharmacol Biochem Behav; 2002 May; 72(1-2); 29-37
Richard Rabin, Regina, MJ, Doat, MM, Jerrold Winter; 5-HT2A receptor-stimulated phosphoinosistide hydrolysis in the stimulus effects of hallucinogens; Pharmacol Biochem Behav; 2002; 72; 29-37
Eckler, JR, Doat, M, Richard Rabin, Jerrold Winter; Potentiation of DOM-induced stimulus control by fluoretine and citalopram: the role of pharmacokinetics; Life Sci; 2002; 71; 1341-1347
Doat, MM, Richard Rabin, Jerrold Winter; The effect of chronic treatment with clozapine and haloperidol on the stimulus effects of DOM; Int J Neuropharmacol; 2002; 5; 153-158
Jerrold Winter, Eckler, JR, Richard Rabin, Doat, MM; The Effects of Acute and Chronic Treatment with Fluoxetine and Citalopram on Stimulus Control by DOM; Pharmacol Biochem Behav; 2002; 74; 95-101
Eckler, JR, Richard Rabin, Greizerstein, H, Jerrold Winter; A sensitive method for determining levels of [-]-2,5-dimethoxy-4-methylamphetamine in brain tissue; J Pharmacol Toxicol Methods; 2001; 46; 37-43
Winter JC, Doat M, Rabin RA; Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia.; Life Sci; 2000 Dec; 68(3); 337-344
Rabin RA, Doat M, Winter JC; Role of serotonergic 5-HT2A receptors in the psychotomimetic actions of phencyclidine.; Int J Neuropsychopharmacol; 2000 Dec; 3(4); 333-338
Richard Rabin, Doat, M., Jerrold Winter; Role of serotonergic 5-HT2A receptors in the psychotomimetic actions of phencyclidine; Int J Neuropsychopharmacol; 2000; 3; 333-338
Winter JC, Filipink RA, Timineri D, Helsley SE, Rabin RA; The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.; Pharmacol Biochem Behav; 2000 Jan; 65(1); 75-82
Winter JC, Fiorella DJ, Timineri DM, Filipink RA, Helsley SE, Rabin RA; Serotonergic receptor subtypes and hallucinogen-induced stimulus control.; Pharmacol Biochem Behav; 1999 Oct; 64(2); 283-293
Winter JC, Helsley S, Fiorella D, Rabin RA; The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.; Pharmacol Biochem Behav; 1999 Jul; 63(3); 507-513
Winter JC, Timineri D; The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba.; Pharmacol Biochem Behav; 1999 Mar; 62(3); 543-547
Helsley S, Rabin RA, Winter JC; Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus.; Prog Neuropsychopharmacol Biol Psychiatry; 1999 Feb; 23(2); 317-326
Helsley, S, Richard Rabin, Jerrold Winter; Drug discrimination studies with ibogaine; Ibogaine; 1999;
Jerrold Winter, Fiorella, DJ, Helsley, SE, Richard Rabin; Partial Generalization of (-)DOM to Fluvoxamine in the Rat: Implications for SSRI-induced Mania and Psychosis; Int J Neuropsychopharmacol; 1999; 2; 165-172
Helsley S, Siegel TL, Fiorella D, Rabin RA, Winter JC; WAY-100635 reverses 8-OH-DPAT-induced performance impairment in the radial maze.; Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7); 1179-1184
Winter JC, Helsley SE, Rabin RA; The discriminative stimulus effects of KA 672, a putative cognitive enhancer: evidence for a 5-HT1A component.; Pharmacol Biochem Behav; 1998 Jul; 60(3); 703-707
Helsley S, Fiorella D, Rabin RA, Winter JC; A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.; Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4); 649-663
Helsley S, Rabin RA, Winter JC; The effects of beta-carbolines in rats trained with ibogaine as a discriminative stimulus.; Eur J Pharmacol; 1998 Mar; 345(2); 139-143
Helsley S, Fiorella D, Rabin RA, Winter JC; Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.; Pharmacol Biochem Behav; 1998 Feb; 59(2); 419-425
Winter JC; The effects of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and longevity in the rat.; Physiol Behav; 1998 Feb; 63(3); 425-433
Helsley S, Filipink RA, Bowen WD, Rabin RA, Winter JC; The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.; Pharmacol Biochem Behav; 1998 Feb; 59(2); 495-503
Fiorella D, Helsley S, Rabin RA, Winter JC; Further investigations of the interactions of antipsychotics with the (-)2,5-dimethoxy-4-methylamphetamine (DOM) discriminative stimulus.; Neuropharmacology; 1997 Oct; 36(10); 1463-1469
Helsley S, Fiorella D, Rabin RA, Winter JC; Effects of ibogaine on performance in the 8-arm radial maze.; Pharmacol Biochem Behav; 1997 Sep; 58(1); 37-41
Johnson RG, Fiorella D, Winter JC, Rabin RA; [3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe.; Eur J Pharmacol; 1997 Jun; 329(1); 99-106
Helsley S, Dlugos CA, Pentney RJ, Rabin RA, Winter JC; Effects of chronic ibogaine treatment on cerebellar Purkinje cells in the rat.; Brain Res; 1997 Jun; 759(2); 306-308
Winter JC; The effects of age on continuous learning in the radial maze.; Physiol Behav; 1997 Apr; 61(4); 609-612
Helsley S, Rabin RA, Winter JC; The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus.; Life Sci; 1997 Jan; 60(9); 147-153
Rabin RA, Winter JC; Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors.; Eur J Pharmacol; 1996 Dec; 316(2-3); 343-348
Rabin RA, Winter JC; Effects of ibogaine and noribogaine on phosphoinositide hydrolysis.; Brain Res; 1996 Aug; 731(1-2); 226-229
Fiorella D, Helsley S, Rabin RA, Winter JC; Potentiation of LSD-induced stimulus control by fluoxetine in the rat.; Life Sci; 1996 Jan; 59(18); 283-287
Fiorella D, Rabin RA, Winter JC; The interaction of clozapine with the meta-chlorophenylpiperazine (mCPP) discriminative stimulus.; Life Sci; 1996 Jan; 58(24); 353-358
Fiorella D, Helsley S, Rabin RA, Winter JC; 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.; Psychopharmacology (Berl); 1995 Dec; 122(3); 237-243
Fiorella D, Rabin RA, Winter JC; Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.; Psychopharmacology (Berl); 1995 Oct; 121(3); 357-363
Fiorella D, Helsley S, Rabin RA, Winter JC; The interactions of typical and atypical antipsychotics with the (-)2, 5,-dimethoxy-4-methamphetamine (DOM) discriminative stimulus.; Neuropharmacology; 1995 Oct; 34(10); 1297-1303
Fiorella D, Rabin RA, Winter JC; The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.; Psychopharmacology (Berl); 1995 Oct; 121(3); 347-356
Fiorella D, Helsley S, Lorrain DS, Rabin RA, Winter JC; The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.; Psychopharmacology (Berl); 1995 Oct; 121(3); 364-372
Fiorella D, Rabin RA, Winter JC; The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.; Psychopharmacology (Berl); 1995 May; 119(2); 222-230
Fiorella D, Palumbo PA, Rabin RA, Winter JC; The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.; Psychopharmacology (Berl); 1995 May; 119(2); 239-245
Bonson KR, Johnson RG, Fiorella D, Rabin RA, Winter JC; Serotonergic control of androgen-induced dominance.; Pharmacol Biochem Behav; 1994 Oct; 49(2); 313-322
Palumbo PA, Winter JC; Interactions of clozapine with the stimulus effects of DOM and LSD.; Pharmacol Biochem Behav; 1994 Sep; 49(1); 115-120
Winter JC, Rabin RA; Discriminative stimulus properties of m-chlorophenylpiperazine.; Pharmacol Biochem Behav; 1993 May; 45(1); 221-223
Winter JC, Rabin RA; Antagonism of the stimulus effects of yohimbine and 8-hydroxydipropylaminotetralin.; Pharmacol Biochem Behav; 1993 Apr; 44(4); 851-855
Rabin RA, Winter JC; Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin.; Eur J Pharmacol; 1993 Apr; 235(2-3); 237-243
Palumbo PA, Winter JC; Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.; Pharmacol Biochem Behav; 1992 Dec; 43(4); 1221-1226
Winter JC, Rabin RA; Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination.; J Pharmacol Exp Ther; 1992 Nov; 263(2); 682-689
Bonson KR, Winter JC; Reversal of testosterone-induced dominance by the serotonergic agonist quipazine.; Pharmacol Biochem Behav; 1992 Aug; 42(4); 809-813
McCann DJ, Rabin RA, Rens-Domiano S, Winter JC; Phencyclidine/SKF-10,047 binding sites: evaluation of function.; Pharmacol Biochem Behav; 1989 Jan; 32(1); 87-94
Winter J, Rabin R; Yohimbine and serotonergic agonists: Stimulus properties and receptor binding.; Drug Dev. Res.; 1989 Jan; 16; 327-333
Winter JC, Rabin RA; A comparison of the discriminative stimulus properties of l-5-hydroxytryptophan in the presence of either citalopram or Ro 4-4602.; Pharmacol Biochem Behav; 1988 Jul; 30(3); 613-616
Winter JC, Rabin RA; Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.; Pharmacol Biochem Behav; 1988 Jul; 30(3); 617-624
Winter JC; Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine.; Pharmacol Biochem Behav; 1988 Jan; 29(1); 193-195
Winter JC, Petti DT; The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory.; Pharmacol Biochem Behav; 1987 Aug; 27(4); 625-628
McCann DJ, Rabin RA, Winter JC; Interactions of clonidine with phencyclidine and ketamine: studies of radial maze performance and righting reflex in rats.; Pharmacol Biochem Behav; 1987 Jan; 26(1); 23-28
McCann DJ, Rabin RA, Winter JC; Use of the radial maze in studies of phencyclidine and other drugs of abuse.; Physiol Behav; 1987; 40(6); 805-812
Winter JC; Verapamil does not antagonize LSD-induced stimulus control.; Pharmacol Biochem Behav; 1986 Jul; 25(1); 227-228
McCann DJ, Smith CM, Winter JC; A caution against use of verapamil in phencyclidine intoxication.; Am J Psychiatry; 1986 May; 143(5); 679-679
McCann DJ, Winter JC; Effects of phencyclidine, N-allyl-N-normetazocine (SKF-10,047), and verapamil on performance in a radial maze.; Pharmacol Biochem Behav; 1986 Feb; 24(2); 187-191
Winter JC; Linolenic acid deficiency.; Arch Neurol; 1985 Jan; 42(1); 15-16
Winter JC; Sedation and the stimulus properties of antihistamines.; Pharmacol Biochem Behav; 1985 Jan; 22(1); 15-17
Winter JC; The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.; Pharmacol Biochem Behav; 1984 Feb; 20(2); 201-203
Winter JC; Caffeine-induced stimulus control.; Pharmacol Biochem Behav; 1981 Aug; 15(2); 157-159
Frey LG, Winter JC; Comparison of the discriminative stimulus properties of nefopam and morphine.; Psychopharmacology (Berl); 1979 Mar; 61(2); 231-232
Winter JC; Quipazine-induced stimulus control in the rat.; Psychopharmacology (Berl); 1979 Feb; 60(3); 265-269
Winter JC; Yohimbine-induced stimulus control in the rat.; Arch Int Pharmacodyn Ther; 1978 Sep; 235(1); 86-92
Winter JC; Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.; J Pharmacol Exp Ther; 1978 Feb; 204(2); 416-423
Winter JC; Morphine and ethanol as discriminative stimuli: absence of antagonism by p-chlorophenylalanine methyl ester, cinanserin, or BC-105.; Psychopharmacology (Berl); 1977 Jul; 53(2); 159-163
Winter JC; The stimulus properties of morphine and ethanol.; Psychopharmacologia; 1975 Nov; 44(3); 209-214
York JL, Winter JC; Assessment of tolerance to barbital by means of drug discrimination procedures.; Psychopharmacologia; 1975 Jun; 42(3); 283-287
York JL, Winter JC; Long-term effects of barbital on spontaneous activity of rats trained to use the drug as a discriminative stimulus.; Psychopharmacologia; 1975 Apr; 42(1); 47-50
Winter JC; The effects of 3,4-dimethoxyphenylethylamine in rats trained with mescaline as a discriminative stimulus.; J Pharmacol Exp Ther; 1974 Jun; 189(3); 741-747
Oglesby MW, Winter JC; Strychnine sulfate and piracetam: lack of effect on learning in the rat.; Psychopharmacologia; 1974 Apr; 36(2); 163-173
Oglesby MW, Rosenberg J, Winter JC; Behavioral and biochemical effects of chronic administration of bromide in the rat.; Psychopharmacologia; 1973 Aug; 32(1); 85-92
Sethy VH, Winter JC; Effect of chronic treatment with mescaline upon tissue levels of the drug.; Experientia; 1973 May; 29(5); 571-572
Winter JC; A comparison of the stimulus properties of mescaline and 2,3,4-trimethoxyphenylethylamine.; J Pharmacol Exp Ther; 1973 Apr; 185(1); 101-107
Frey LG, Winter JC; Effects of p-acetyldeoxyephedrine on punished behavior in the rat.; Arch Int Pharmacodyn Ther; 1973 Jan; 201(1); 125-127
Winter JC; Comparison of chlordiazepoxide, methysergide, and cinanserin as modifiers of punished behavior and as antagonists of N,N-dimethyltryptamine.; Arch Int Pharmacodyn Ther; 1972 May; 197(1); 147-159
Schechter MD, Winter JC; Effect of BOL on the LSD-induced alteration of flicker discrimination in the rat.; Arch Int Pharmacodyn Ther; 1972 Mar; 196(1); 64-69
Winter JC; Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.; J Pharmacol Exp Ther; 1971 Sep; 178(3); 625-630
Schechter MD, Winter JC; Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.; J Pharmacol Exp Ther; 1971 May; 177(2); 461-467
Winter JC; Interaction of serotonin antagonists with harmaline-induced changes in operant behavior and body temperature in the rat.; Arch Int Pharmacodyn Ther; 1971 May; 191(1); 120-132
Winter JC; Behavioral effects of N,N-diethyltryptamine: absence of antagonism by xylamidine tosylate.; J Pharmacol Exp Ther; 1969 Sep; 169(1); 7-16
Winter JC, Gessner PK; Phenoxybenzamine antagonism of tryptamines, their indene isosteres and 5-hydroxytryptamine in the rat stomach fundus preparation.; J Pharmacol Exp Ther; 1968 Aug; 162(2); 286-293
Winter JC, Gessner PK, Godse DD; Synthesis of some 3-indenealkylamines. Comparison of the biological activity of 3-indenealkylamines and 3-benzo[b]thiophenealkylamines with their tryptamine isosteres.; J Med Chem; 1967 Sep; 10(5); 856-858
McCann, DJ, Smith, CM, Jerrold Winter; A caution against use of verapamil in phencyclidine intoxication; Amer J Psychiat; 143; 679-679
Eckler JR, Greizerstein H, Rabin RA, Winter JC; A sensitive method for determining levels of [-]-2,5,-dimethoxy-4-methylamphetamine in the brain tissue.; J Pharmacol Toxicol Methods; 46(1); 37-43
Smith, CM, Bonson, KR, Jerrold Winter, Roger Cunningham; Adverse drug reactions and interactions; Essentials of Pharmacology;
Jerrold Winter; Antipsychotic drugs [Neuroleptics]; Essentials of Pharmacology;
Schechter, MD, Jerrold Winter; Behavioral determination of critical flicker fusion frequency in the rat; Percep Mtr Skills; 29; 655-660
Jerrold Winter; Blockade of the stimulus properties of mescaline by a serotonergic antagonist; Arch int Pharmacodyn Ther; 214; 250-253
Frey, LG, Jerrold Winter; Current trends in the study of drugs as discriminative stimuli.; Drug Discrimination and State Dependent Learning;
Hirschhorn ID, Winter JC; Differences in the stimulus properties of barbital and hallucinogens.; Pharmacol Biochem Behav; 3(3); 343-347
Jerrold Winter; Differential antagonism of the hypothermic effects of N,N-dimethyltryptamine, bufotenin, and 5-methoxytryptamine; Arch Int Pharmacodyn Ther; 198; 61-66
Overton, DA, Jerrold Winter; Discriminable properties of drugs and state-dependent learning; Fed Proc; 33; 1785-1786
Frey LG, Winter JC; Discriminative stimulus properties of intravenous morphine in the rat.; Psychopharmacology (Berl); 66(3); 263-266
Jerrold Winter; Dose-effect relationships, interactions, and therapeutic index; Textbook of Pharmacology;
Jerrold Winter; Drug absorption, distribution, and termination of drug action; Textbook of Pharmacology;
Helsley S, Rabin RA, Winter JC; Drug discrimination studies with ibogaine.; Alkaloids Chem Biol; 56; 63-77
Smith, CM, Jerrold Winter; Drug therapies in obesity and attention deficit disorder; Essentials of Pharmacology;
Bonson, KR, Smith, CM, Jerrold Winter; Drug-induced psychiatric symptoms; Textbook of Pharmacology;
Jerrold Winter; Drug-induced stimulus control; Contemporary Research in Behavioral Pharmacology;
Winter JC; Drug-induced stimulus control and the concept of breaking point: LSD and quipazine.; Psychopharmacology (Berl); 72(2); 217-218
Winter JC; Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus.; Psychopharmacology (Berl); 68(2); 159-162
Sethy, VH, Jerrold Winter; Effects of yohimbine and mescaline on punished behavior in the rat; Psychopharmacologia; 23; 160-166
Sethy VH, Winter JC; Effects of yohimbine and mescaline on punished behavior in the rat.; Psychopharmacologia; 23(2); 160-166
Jerrold Winter; Effectsof phenethylamine derivatives, BL-3912, fenfluramine, and SCG-12,679 in rats trained with LSD as a discriminative stimulus; Psychopharmacology; 68; 159-162
Jerrold Winter; Hallucinogens as discriminative stimuli; Fed Proc; 33; 1825-1832
Jerrold Winter; Introduction to pharmacology; Essentials of Pharmacology;
Jerrold Winter; Introduction to pharmacology: Receptors; Textbook of Pharmacology;
Hirschhorn, I., Jerrold Winter; Mescaline and LSD as discriminative stimuli; Psychopharmacologia; 22; 64-71
Hirschhorn ID, Winter JC; Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli.; Psychopharmacologia; 22(1); 64-71
Winter JC; Phencyclidine-induced Stimulus Control in the Rat:: Interactions with Other Psychoactive Drugs; Pharmacol Biochem Behav, in press, 2007;
Fiorella D, Helsley S, Rabin RA, Winter JC; Potentiation of LSD-induced stimulus control by fluoxetine in the rat.; Life Sci; 59(18); 283-287
Jerrold Winter; Propranolol and morphine: A lethal interaction; Arch int Pharmacodyn Ther; 212; 195-198
Winter JC; Relationship between sources of knowledge and use of research findings.; J Contin Educ Nurs; 21(3); 138-140
Jerrold Winter; Routes of administration; Essentials of Pharmacology;
Jerrold Winter; Routes of administration; Textbook of Pharmacology;
Jerrold Winter, Peter Gessner, Godse, DD; Synthesis and preliminary pharmacology of indene isosteres of substituted tryptamines; J Med Chem; 10; 856-859
Jerrold Winter, Peter Gessner, Godse, DD; Synthesis of 5- and 6-methoxyindene; J Org Chem; 30; 3231-3233
Jerrold Winter; The behavioral pharmacology of psychoactive drugs; Psychopharmacol Bul; 11; 63-64
Jerrold Winter; The effects of 2,5-dimethoxy-4-methylamphetamine [DOM], 2,5-dimethoxy-4-ethylamphetamine [DOET], d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus; Pschopharmacologia; 14; 209-214
Jerrold Winter, Petti, DT; The effects of DPAT and other serotonergic agonists on performance in a radial maze: A possible role for 5-HT1A receptors in memory; Pharmacol Biochem Behav; 27; 625-628
Helsley S, Rabin RA, Winter JC; The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus.; Life Sci; 60(9); 147-153
Fiorella D, Rabin RA, Winter JC; The interaction of clozapine with the meta-chlorophenylpiperazine (mCPP) discriminative stimulus.; Life Sci; 58(24); 353-358
Jerrold Winter; The radial maze in behavioral pharmacology and toxicology; Physiol Behav; 40; 791-791
Jerrold Winter; The redemonizing of marijuana; Pharmaceutical News; 5; 22-27
Jerrold Winter; The stimulus effects of serotonergic hallucinogens in animals; NIDA Monograph No 146, Hallucinogens, An Update;
Winter JC; The stimulus effects of serotonergic hallucinogens in animals.; NIDA Res Monogr; 146; 157-182
Winter JC; The stimulus properties of gamma-hydroxybutyrate.; Psychopharmacology (Berl); 73(4); 372-375
Palumbo, PA, Jerrold Winter; The stimulus properties of ibogaine in rats trained with yohimbine, DOM, and LSD; Pharmacol Biochem Behav; 43; 1221-1226
Jerrold Winter; The stimulus properties of p-methoxyamphetamine: A nonessential serotonergic component; Pharmacol Biochem Behav; 20; 201-203
Jerrold Winter; Tolerance, physical dependence, and drug abuse; Essentials of Pharmacology;
Jerrold Winter; True Nutrition, True Fitness;
Winter JC; Xylamidine tosylate: differential antagonism of the hypothermic effects of N,N-dimethyltryptamine, bufotenine, and 5-methoxytryptamine.; Arch Int Pharmacodyn Ther; 198(1); 61-66
Jerrold Winter; Yohimbine-induced stimulus control in the rat; Arch int Pharmacodyn Ther; 235; 86-92


GRANTS


The behavioral and Pharmacological analysis of drugs of abuse
Jerrold Winter



 
Dr. Jerrold Winter
Dr. Jerrold Winter